Health & Medicine
-
Study Points to New Drug Target in Fight Against Cancer
In a study this week in the Proceedings of the National Academy of Sciences, an international team of researchers describes how a cancer-linked version of the protein mitoNEET can close the primary gateways in the outer surface of mitochondria, the "power plants" that supply cells with chemical energy. These gateways, or "voltage-dependent anion channels" (VDACs), normally open and close to allow the passage of metabolites and other small molecules between mitochondria and the rest of the cell.
Latest Research Articles
-
More than Lyme: Tick Study Finds Multiple Agents of Tick-Borne Diseases
-
'Death Star' Bacterial Structures that Inject Proteins Can be Tapped to Deliver Drugs
-
Antibiotic Resistance Surges in Dolphins, Mirroring Humans
-
Few People with Peanut Allergy Tolerate Peanut After Stopping Oral Immunotherapy
-
Cancer Cells Prefer a 'Comfort Cruise,' Follow Predictable Paths of Least Resistance
-
Researchers Have Identified Areas of the Retina That Change in Mild Alzheimer's Disease
-
Why Young Females with Obesity are at Early Risk for Cardiovascular Disease
-
Bias Against Single People Affects Their Cancer Treatment
-
Scientists Triple Storage Time of Human Donor Livers
-
Genetic Mutation Linked to Flu-Related Heart Complications
-
Feeding Dogs and Cats with Raw Food is Not Considered a Significant Source of Infections
-
Tweets Indicate Nicotine Dependence, Withdrawal Symptoms of JUUL Users